{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:50:32Z","timestamp":1791409832858,"version":"4.3.3"},"reference-count":120,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bioorg.2026.110410","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T23:35:22Z","timestamp":1787268922000},"page":"110410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Green synthesis of N-aryl-1-(2-bromo-4-methyl phenyl)-1H-tetrazol-5-amines as novel anti-cancer agents targeting tubulin-Combretastatin A4 complex and human non-small cell lung cancer cell lines"],"prefix":"10.1016","volume":"181","author":[{"given":"Uma Ravi Sankar","family":"Arigala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raju","family":"Vasantham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santhosh Kumar","family":"Nadikatla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim Khalivulla","family":"Shaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yellappa","family":"Masapogu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.110410_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bioorg.2026.110410_bb0015","doi-asserted-by":"crossref","DOI":"10.1080\/15592294.2025.2536786","article-title":"The role of histone methyltransferases in therapeutic resistance of NSCLC","volume":"20","author":"Zhu","year":"2025","journal-title":"Epigenetics"},{"key":"10.1016\/j.bioorg.2026.110410_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14031025","article-title":"NSCLC: current evidence on its pathogenesis, integrated treatment, and future perspectives","volume":"14","author":"Tahayneh","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bioorg.2026.110410_bb0025","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13045-025-01679-1","article-title":"Recent advances in therapeutic strategies for non-small cell lung cancer","volume":"18","author":"Su","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bioorg.2026.110410_bb0030","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3390\/cancers17030459","article-title":"Optimizing osimertinib for NSCLC: targeting resistance and exploring combination therapeutics","volume":"17","author":"Liao","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.bioorg.2026.110410_bb0035","doi-asserted-by":"crossref","DOI":"10.2147\/CMAR.S551239","article-title":"Targeting oncogenic miRNAs in NSCLC: therapeutic strategies and emerging approaches","volume":"18","author":"Su","year":"2026","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.bioorg.2026.110410_bb0040","first-page":"5409","article-title":"Nrf2 is a key factor in the reversal effect of curcumin on multidrug resistance in the HCT-8\/5-Fu human colorectal cancer cell line","volume":"18","author":"Zhang","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bioorg.2026.110410_bb0045","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.3389\/fphar.2019.01178","article-title":"Piperlongumine inhibits Akt phosphorylation to reverse resistance to cisplatin in human non-small cell lung cancer cells via ROS regulation","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.110410_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104401","article-title":"Design, synthesis, and biological evaluation of a novel indoleamine 2,3-dioxygenase 1 (IDO1) and thioredoxin reductase (TrxR) dual inhibitor","volume":"105","author":"Fan","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0055","doi-asserted-by":"crossref","first-page":"56738","DOI":"10.1039\/C6RA11398B","article-title":"Discovery of novel chemical scaffolds as RhoA inhibitors using virtual screening, synthesis, and bioactivity evaluation","volume":"6","author":"Zhang","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2026.110410_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.107076","article-title":"Tubulin inhibitors: selected scaffolds and main trends in the design of novel anticancer and antiparasitic agents","volume":"143","author":"Podolak","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0065","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1080\/14656566.2024.2369196","article-title":"Updates in pharmacotherapy for non-small cell lung cancer: a focus on emerging tubulin inhibitors","volume":"25","author":"Nardin","year":"2024","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.bioorg.2026.110410_bb0070","first-page":"4020","article-title":"A review of research progress of antitumor drugs based on tubulin targets, Transl","volume":"9","author":"Cheng","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2026.110410_bb0075","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41420-025-02679-3","article-title":"Discovery of a novel potent tubulin inhibitor through virtual screening and target validation for cancer chemotherapy","volume":"11","author":"Shan","year":"2025","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.bioorg.2026.110410_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28020802","article-title":"Identification of potential antitubulin agents with anticancer assets from a series of imidazo[1,2-a]quinoxaline derivatives: in silico and in vitro approaches","volume":"28","author":"Goel","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110410_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102063","article-title":"A novel tubulin inhibitor, 6h, suppresses tumor-associated angiogenesis and shows potent antitumor activity against non-small cell lung cancers","volume":"298","author":"Liu","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2025.123644","article-title":"A novel tubulin inhibitor, No.07, shows anti-cancer and anti-metastatic effects in colon cancer and tumoroids","volume":"372","author":"Han","year":"2025","journal-title":"Life Sci."},{"key":"10.1016\/j.bioorg.2026.110410_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107930","article-title":"Combretastatin A-4 based compounds as potential anticancer agents: a review","volume":"153","author":"Omar","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25112560","article-title":"Combretastatins: an overview of structure, probable mechanisms of action and potential applications","volume":"25","author":"Karatoprak","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110410_bb0105","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2174\/092986711794480221","article-title":"Developments of Combretastatin A-4 derivatives as anticancer agents","volume":"18","author":"Shan","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0110","doi-asserted-by":"crossref","first-page":"8021","DOI":"10.1021\/acs.nanolett.9b03214","article-title":"Combretastatin A4 nanoparticles combined with hypoxia-sensitive imiquimod: a new paradigm for the modulation of host immunological responses during cancer treatment","volume":"19","author":"Shen","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.bioorg.2026.110410_bb0115","doi-asserted-by":"crossref","DOI":"10.1039\/C8OB01148F","article-title":"Synthesis and biological evaluation of cyclic derivatives of Combretastatin A-4 containing group 14 elements","author":"Blasco","year":"2018","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0120","doi-asserted-by":"crossref","first-page":"8559","DOI":"10.1021\/jacs.1c03013","article-title":"Regulating the anticancer efficacy of Sgc8\u2013Combretastatin A4 conjugates: a case of recognizing the significance of linker chemistry for the design of aptamer-based targeted drug delivery strategies","volume":"143","author":"Huang","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2026.110410_bb0125","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jnatprod.9b00773","article-title":"Bioreductively activatable prodrug conjugates of Combretastatin A-1 and Combretastatin A-4 as anticancer agents targeted toward tumor-associated hypoxia","author":"Winn","year":"2020","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2026.110410_bb0130","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1158\/1078-0432.CCR-04-1434","article-title":"Phase I trial of combretastatin A-4 phosphate with carboplatin","volume":"11","author":"Bilenker","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2026.110410_bb0135","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1021\/jm2013979","article-title":"Synthesis and evaluation of 1,5-disubstituted tetrazoles as rigid analogues of Combretastatin A-4 with potent antiproliferative and antitumor activity","volume":"55","author":"Romagnoli","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241311093","article-title":"Novel tetrazole derivatives targeting tubulin endowed with antiproliferative activity against glioblastoma cells","volume":"24","author":"Gallego-Yerga","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110410_bb0145","doi-asserted-by":"crossref","DOI":"10.1039\/C9MD00458K","article-title":"Application of triazoles as bioisosteres and linkers in the development of microtubule targeting agents","author":"Malik","year":"2020","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0150","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1039\/D3MD00746D","article-title":"1,5-Disubstituted tetrazoles as PD-1\/PD-L1 antagonists","volume":"15","author":"van der Straat","year":"2024","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0155","doi-asserted-by":"crossref","first-page":"19908","DOI":"10.1021\/acs.jmedchem.5c00014","article-title":"Discovery of novel 4,5-dihydropyrrolo[3,4-c]pyrazol-6(2H)-one-based tubulin inhibitors targeting the colchicine binding site as potent antitumor agents","volume":"68","author":"Yu","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0160","article-title":"Coumarin-30 enables site-resolved detection of tubulin ligands by microscale thermophoresis","volume":"65","author":"Anisimov","year":"2026","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2026.110410_bb0165","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/ph13010008","article-title":"Colchicine-binding site inhibitors from chemistry to clinic: a review","volume":"13","author":"McLoughlin","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2026.110410_bb0170","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1007\/s11095-012-0828-z","article-title":"An overview of tubulin inhibitors that interact with the colchicine binding site","volume":"29","author":"Lu","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.bioorg.2026.110410_bb0175","doi-asserted-by":"crossref","first-page":"7877","DOI":"10.1021\/acs.jmedchem.8b00827","article-title":"Structural modification of the 3,4,5-trimethoxyphenyl moiety in the tubulin inhibitor VERU-111 leads to improved antiproliferative activities","volume":"61","author":"Wang","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0180","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.3390\/pharmaceutics15122728","article-title":"Podophyllotoxin: recent advances in the development of hybridization strategies to enhance its antitumoral profile","volume":"15","author":"Miranda-Vera","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioorg.2026.110410_bb0185","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.1016\/j.bmcl.2009.06.079","article-title":"Discovery of CYT997: a structurally novel orally active microtubule targeting agent","volume":"19","author":"Burns","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110410_bb0190","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0960-894X(01)00098-1","article-title":"Novel sulfonate analogues of combretastatin A-4: potent antimitotic agents","volume":"11","author":"Gwaltney","year":"2001","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110410_bb0195","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1021\/acs.jmedchem.7b01858","article-title":"Heterocyclic-fused pyrimidines as novel tubulin polymerization inhibitors targeting the colchicine binding site: structural basis and antitumor efficacy","volume":"61","author":"Banerjee","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0200","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/CAD.0b013e32832c0acf","article-title":"ABT-751, a novel tubulin-binding agent, decreases tumor perfusion and disrupts tumor vasculature","volume":"20","author":"Luo","year":"2009","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.bioorg.2026.110410_bb0205","doi-asserted-by":"crossref","first-page":"5686","DOI":"10.1073\/pnas.96.10.5686","article-title":"Selective, covalent modification of \u03b2-tubulin residue Cys-239 by T138067, an antitumor agent with in vivo efficacy against multidrug-resistant tumors","volume":"96","author":"Shan","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bioorg.2026.110410_bb0210","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s40265-022-01734-y","article-title":"Oteseconazole: first approval","volume":"82","author":"Hoy","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.bioorg.2026.110410_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252313014","article-title":"Cenobamate, a new promising antiseizure medication: experimental and clinical aspects","volume":"25","author":"B\u0142aszczyk","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110410_bb0220","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2147\/CE.S187499","article-title":"Tedizolid phosphate for the treatment of acute bacterial skin and skin-structure infections: an evidence-based review of its place in therapy","volume":"14","author":"Bassetti","year":"2019","journal-title":"Core Evid."},{"key":"10.1016\/j.bioorg.2026.110410_bb0225","first-page":"113","article-title":"Impact of olmesartan on blood pressure, endothelial function, and cardiovascular outcomes","volume":"3","author":"Pimenta","year":"2010","journal-title":"Integr. Blood Pressure Control"},{"key":"10.1016\/j.bioorg.2026.110410_bb0230","doi-asserted-by":"crossref","first-page":"991","DOI":"10.2165\/00003495-200363100-00005","article-title":"Pranlukast: a review of its use in the management of asthma","volume":"63","author":"Keam","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.bioorg.2026.110410_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115126","article-title":"Bioisosteric replacement of 1H-1,2,3-triazole with 1H-tetrazole ring enhances anti-leukemic activity of (5-benzylthiazol-2-yl)benzamides","volume":"250","author":"Pokhodylo","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.109301","article-title":"Discovery of novel quinazoline analogs as tubulin inhibitors targeting the colchicine binding site for potent antitumor therapy in combination with PD-L1 inhibitors","volume":"168","author":"Ren","year":"2026","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108844","article-title":"Design and synthesis of tetrazole tethered quinazoline derivatives via azide-isocyanide cross-coupling reaction: exploring the utility as anticancer agents via SRC kinase inhibition in breast cancer","volume":"164","author":"Zou","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0250","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s41573-023-00774-7","article-title":"Artificial intelligence for natural product drug discovery","volume":"22","author":"Mullowney","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2026.110410_bb0255","doi-asserted-by":"crossref","first-page":"17319","DOI":"10.1021\/acs.jmedchem.4c01223","article-title":"Discovery of novel PROTAC SIRT6 degraders with potent efficacy against hepatocellular carcinoma","volume":"67","author":"Huang","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0260","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1039\/D2SC06860E","article-title":"Discovery of a photoactivatable dimerized STING agonist based on the benzo[b]selenophene scaffold","volume":"14","author":"Liu","year":"2023","journal-title":"Chem. Sci."},{"key":"10.1016\/j.bioorg.2026.110410_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113091","article-title":"Discovery of selective CDK9 degraders with enhanced antiprolifeative activity through PROTAC conversion","volume":"211","author":"Qiu","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.140125","article-title":"Discovery of novel thiophene[2,3-d]pyrimidine-thiazole derivatives as promising MNK inhibitors for breast cancer treatment","volume":"1321","author":"Zhu","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.110410_bb0275","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1021\/acs.jmedchem.4c02805","article-title":"Discovery of an orally efficacious pyrazolo[3,4-d]pyrimidine benzoxaborole as a potent inhibitor of Cryptosporidium","volume":"68","author":"Gasonoo","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114860","article-title":"Discovery of novel hydroxyamidine-based indoleamine 2,3-dioxygenase 1 (IDO1) and thioredoxin reductase 1 (TrxR1) dual inhibitors","volume":"245","author":"Zhou","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0285","doi-asserted-by":"crossref","first-page":"14365","DOI":"10.1021\/acs.jmedchem.6c00065","article-title":"Lead optimization of TgCDPK1 inhibitors for the treatment of toxoplasmosis","volume":"69","author":"Mannino","year":"2026","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.109178","article-title":"Ethyl 4-(1H-tetrazol-1-yl)benzoate derivatives as multi-target inhibitors of cancer migration via BTK, BRAF, and FAK modulation: in silico and in vitro studies","volume":"167","author":"Mekky","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.108029","article-title":"Development of novel tetrazole-based pyruvate kinase M2 inhibitors targeting U87MG glioblastoma cells","volume":"154","author":"Chowdhury","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2026.110163","article-title":"Microwave-assisted green synthesis and biological evaluation of a novel isatin-thiazole-benzofuran hybrid with dual acetylcholinesterase inhibitory and antioxidant activities","volume":"180","author":"Lotfy","year":"2026","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.109231","article-title":"Green and sustainable approaches to quinazolie-based anticancer agents: synthesis and structure\u2013activity relationship (SAR)","volume":"167","author":"Kumari","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107936","article-title":"Eco-conscious synthesis of novel 1,2,4-triazolo[1,5-a]pyrimidine derivatives as potent antimicrobial agents and comparative study of cell viability and cytotoxicity in HEK-293 cell line utilizing Indian gooseberry (Phyllanthus emblica) fruit extract","volume":"153","author":"Bhatt","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2026.110270","article-title":"Design, synthesis, antimicrobial evaluation, and molecular dynamics-based computational investigation of novel imidazole-based FabI-targeted derivatives with antioxidant, DNA nicking, and cytotoxicity studies","volume":"181","author":"Devliya","year":"2026","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106636","article-title":"Design and synthesis of novel carbohydrate-amino acid hybrids and their antioxidant and anti-\u03b2-amyloid aggregation activity","volume":"137","author":"Tvrdo\u0148ov\u00e1","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108863","article-title":"New dimension of ciprofloxacin hybrids: synthesis, characterization and anticancer evaluation of newly C3-modified ciprofloxacin derivatives","volume":"164","author":"Koszelewski","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2026.109896","article-title":"Design and green synthesis of naphthalimide-based organic molecule for non-enzymatic detection of uric acid in solid and solution state: from molecule to prototype kit","volume":"176","author":"Garg","year":"2026","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2026.109987","article-title":"Green synthesis and biological evaluation of novel thio-\/seleno-imidazo[1,2-a]pyridine derivatives as novel and potent colchicine-site tubulin inhibitors","volume":"179","author":"Wang","year":"2026","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114982","article-title":"1-Benzyloxy-5-phenyltetrazole derivatives highly active against androgen receptor-dependent prostate cancer cells","volume":"246","author":"Zhao","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.114002","article-title":"Design, synthesis and biological evaluation of 1,5-disubstituted \u03b1-amino tetrazole derivatives as non-covalent inflammasome-caspase-1 complex inhibitors with potential application against immune and inflammatory disorders","volume":"229","author":"Ulgheri","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molstruc.2016.09.053","article-title":"Five new complexes based on 1-phenyl-1H-tetrazole-5-thiol: synthesis, structural characterization and properties","volume":"1129","author":"Song","year":"2017","journal-title":"J. Mol. Struct."},{"issue":"20","key":"10.1016\/j.bioorg.2026.110410_bb0355","doi-asserted-by":"crossref","first-page":"6104","DOI":"10.3390\/molecules26206104","article-title":"A one-pot six-component reaction for the synthesis of 1,5-disubstituted tetrazol-1,2,3-triazole hybrids and their cytotoxic activity against the MCF-7 cell line","volume":"26","author":"Aguilar-Morales","year":"2021","journal-title":"Molecules"},{"issue":"11","key":"10.1016\/j.bioorg.2026.110410_bb0360","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.3390\/molecules26113282","article-title":"Substituent effects on EI-MS fragmentation patterns of 5-allyloxy-1-aryl-tetrazoles and 4-allyl-1-aryl-tetrazole-5-ones; correlation with UV-induced fragmentation channels","volume":"26","author":"Secrieru","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110410_bb0365","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1016\/j.bmcl.2016.08.034","article-title":"Structure\u2013activity relationship of novel series of 1,5-disubstituted tetrazoles as cyclooxygenase-2 inhibitors: design, synthesis, bioassay screening and molecular docking studies","volume":"26","author":"Al-Hourani","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"Suppl. 2","key":"10.1016\/j.bioorg.2026.110410_bb0370","doi-asserted-by":"crossref","first-page":"W270","DOI":"10.1093\/nar\/gkr366","article-title":"SwissDock, a protein-small molecule docking web service based on EADock DSS","volume":"39","author":"Grosdidier","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2026.110410_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.138228","article-title":"Development of promising acetylcholinesterase and butyrylcholinesterase inhibitors: synthesis, in vitro and in silico approaches of pyridine-derived fused bis-oxadiazole and bis-thiadiazole derivatives","volume":"1310","author":"Hussain","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.110410_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.carres.2026.110053","article-title":"Design, synthesis, in vitro anticancer evaluation, in silico molecular docking and ADMET profiling of carbohydrate-conjugated pyridine oximes","author":"Ahemad","year":"2026","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.bioorg.2026.110410_bb0385","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1016\/j.chempr.2019.08.022","article-title":"Structure, thermodynamics, and kinetics of plinabulin binding to two tubulin isotypes","volume":"5","author":"La Sala","year":"2019","journal-title":"Chem"},{"key":"10.1016\/j.bioorg.2026.110410_bb0390","doi-asserted-by":"crossref","first-page":"26837","DOI":"10.1021\/acsomega.3c01462","article-title":"Design, synthesis, ADME, and anticancer studies of newer N-aryl-5-(3,4,5-trifluorophenyl)-1,3,4-oxadiazol-2-amines: an insight into experimental and theoretical investigations","volume":"8","author":"Agarwal","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2026.110410_bb0395","article-title":"In silico studies, synthesis, and pharmacological screening of novel multitarget diphenylpyrazole scaffold as EGFR\/BRAF and cyclooxygenase-2 inhibitors","volume":"15","author":"Abdelgawad","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110410_bb0400","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.chempr.2016.12.005","article-title":"Structural basis of cis- and trans-combretastatin binding to tubulin","volume":"2","author":"Gaspari","year":"2017","journal-title":"Chem"},{"key":"10.1016\/j.bioorg.2026.110410_bb0405","doi-asserted-by":"crossref","first-page":"15917","DOI":"10.1039\/C7RA00370F","article-title":"Novel anti-tubulin agents from plant and marine origins: insight from a molecular modeling and dynamics study","volume":"7","author":"Yadava","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2026.110410_bb0410","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.3390\/molecules29102200","article-title":"Novel combretastatin A-4 analogs: design, synthesis, and antiproliferative and anti-tubulin activity","volume":"29","author":"J\u0119drzejczyk","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110410_bb0415","doi-asserted-by":"crossref","first-page":"11560","DOI":"10.1002\/slct.202003170","article-title":"Design and synthesis of new tubulin polymerization inhibitors inspired from Combretastatin A-4: an anticancer agent","volume":"5","author":"Sharma","year":"2020","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioorg.2026.110410_bb0420","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cbpa.2004.06.008","article-title":"Integrating virtual screening in lead discovery","volume":"8","author":"Tudor","year":"2004","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.bioorg.2026.110410_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2025.108789","article-title":"A comprehensive computational and experimental study of novel imidazole-linked thiadiazole-based amide derivatives as dual-target cholinesterase inhibitors for the treatment of Alzheimer's disease","volume":"120","author":"Khan","year":"2026","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0430","article-title":"Identification of bis-thiazole linked oxazine Schiff bases: synthesis, in vitro biological evaluation and computational insights toward potent urease and thymidine phosphorylase inhibitors","author":"Khan","year":"2025","journal-title":"Pure Appl. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0435","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1142\/S2737416526500067","article-title":"Design, synthesis and computational approaches of highly potent thiazole-based isoxazole targeting thymidine phosphorylase and urease inhibitors","volume":"25","author":"Khan","year":"2026","journal-title":"J. Comput. Biophys. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0440","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1142\/S2737416526500018","article-title":"Investigation of in silico DFT, ADMET prediction and molecular docking insight: synthesis and in vitro \u03b1-amylase activity of novel benzoxazole and benzothiazole scaffolds","volume":"25","author":"Sardar","year":"2026","journal-title":"J. Comput. Biophys. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0445","doi-asserted-by":"crossref","first-page":"8883","DOI":"10.1007\/s00210-025-04879-1","article-title":"Design, synthesis and biological profiling of bis-thiazole linked Schiff bases as effective enzyme inhibitors for targeting urease and thymidine phosphorylase proteins","volume":"399","author":"Khan","year":"2026","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.110410_bb0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2025.108741","article-title":"New thiazine derivatives with dual potential for lipoxygenase inhibition and hemolytic activity: synthesis, characterization and molecular docking studies","volume":"120","author":"Khan","year":"2026","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0455","first-page":"3714","article-title":"Fast calculation of molecular polar surface area","volume":"43","author":"Peter","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0460","doi-asserted-by":"crossref","first-page":"5360","DOI":"10.3390\/molecules20045360","article-title":"Galloyl derivatives: synthesis and antiproliferative activity","volume":"20","author":"Marciane","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110410_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2026.145424","article-title":"Scaffold hopping strategy toward novel pyrazolo[3,4-d]pyrimidine-based thiazole frameworks as potential colinesterase inhibitors for treating Alzheimer's disease: insight into in vitro and in silico approaches","volume":"1359","author":"Al-Joufi","year":"2026","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.110410_bb0470","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioorg.2026.110410_bb0475","first-page":"133","article-title":"Quinazoline-tyrphostin antitumor agents","volume":"53","author":"Ahmed","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0480","doi-asserted-by":"crossref","DOI":"10.1515\/pac-2026-0756","article-title":"Thiol-bearing aryl Schiff bases of 2-aminothiophenol as acetylcholinesterase and butyrylcholinesterase inhibitors","author":"Umm-e-Roman","year":"2026","journal-title":"Pure Appl. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2026.110102","article-title":"Structure-guided optimization of N-(5-((2-oxopropyl)thio)-1,3,4-thiadiazol-2-yl)propionamide frameworks as potent SARS-CoV-2 Mpro inhibitors for treating coronavirus disease","volume":"180","author":"Alwethaynani","year":"2026","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0490","article-title":"SAR matrix method in medicinal chemistry","volume":"3","author":"Gupta","year":"2014","journal-title":"F1000Res"},{"key":"10.1016\/j.bioorg.2026.110410_bb0495","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1021\/ci200179y","article-title":"Lessons from molecular scaffold analysis","volume":"51","author":"Hu","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2026.110410_bb0500","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1021\/jm401411z","article-title":"Molecular similarity in medicinal chemistry","volume":"57","author":"Maggiora","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0505","doi-asserted-by":"crossref","first-page":"7667","DOI":"10.1021\/acs.jmedchem.6b00906","article-title":"Identification of analog series and key compounds","volume":"59","author":"Stumpfe","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0510","series-title":"Purification of Laboratory Chemicals","first-page":"103","article-title":"Purification of organic chemicals","author":"Armarego","year":"2013"},{"issue":"1\u20132","key":"10.1016\/j.bioorg.2026.110410_bb0515","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bioorg.2026.110410_bb0520","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/978-1-61779-080-5_20","article-title":"Cell sensitivity assays: the MTT assay","volume":"731","author":"van Meerloo","year":"2011","journal-title":"Methods Mol. Biol."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110410_bb0525","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0022-1759(86)90368-6","article-title":"Rapid colorimetric assay for cell growth and survival: modifications to the tetrazolium dye procedure giving improved sensitivity and reliability","volume":"89","author":"Denizot","year":"1986","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bioorg.2026.110410_bb0535","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera visualization system","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0540","doi-asserted-by":"crossref","first-page":"5862","DOI":"10.1016\/j.ejmech.2010.07.069","article-title":"Oxadiazole derivatives synthesis and antimicrobial activity","volume":"45","author":"Mohammed","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0550","first-page":"3","article-title":"Solubility and permeability estimation","volume":"46","author":"Christopher","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioorg.2026.110410_bb0560","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1039\/D0CS00098A","article-title":"QSAR without borders","volume":"49","author":"Muratov","year":"2020","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bioorg.2026.110410_bb0565","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1021\/acs.jmedchem.3c01093","article-title":"Discovery of novel aminobutanoic acid-based ASCT2 inhibitors for the treatment of non-small-cell lung cancer","volume":"67","author":"Qin","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0570","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.bmcl.2018.12.065","article-title":"Shape-based virtual screening for the discovery of novel CDK8 inhibitor chemotypes","volume":"29","author":"He","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110410_bb0575","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1021\/acs.jmedchem.0c02044","article-title":"Structure-enabled discovery of novel macrocyclic inhibitors targeting the glutaminase 1 allosteric binding site","volume":"64","author":"Xu","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114846","article-title":"The SAR and action mechanisms of autophagy inhibitors that eliminate drug resistance","volume":"244","author":"Ye","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0590","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.foodres.2011.03.031","article-title":"Polyphenol contents and antioxidant activities of kiwifruit extract","volume":"44","author":"Bursal","year":"2011","journal-title":"Food Res. Int."},{"key":"10.1016\/j.bioorg.2026.110410_bb0595","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/wcms.23","article-title":"Similarity searching in medicinal chemistry","volume":"1","author":"Stumpfe","year":"2011","journal-title":"Wiley Interdiscip. Rev. Comput. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110410_bb0600","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1021\/ci700461s","article-title":"SVM-based similarity searching","volume":"48","author":"Geppert","year":"2008","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2026.110410_bb0605","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1021\/ci3001138","article-title":"MMP-cliffs identification","volume":"52","author":"Hu","year":"2012","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2026.110410_bb0610","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.1021\/jm0705713","article-title":"SAR index for structure-activity relationships","volume":"50","author":"Peltason","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110410_bb0620","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13321-015-0109-z","article-title":"ChemDes platform for descriptor computation","volume":"7","author":"Jie","year":"2015","journal-title":"J. Cheminform."},{"key":"10.1016\/j.bioorg.2026.110410_bb0625","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.drudis.2009.04.003","article-title":"Navigating structure-activity landscapes","volume":"14","author":"Bajorath","year":"2009","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioorg.2026.110410_bb0630","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1021\/ci100091e","article-title":"Three-dimensional activity landscapes","volume":"50","author":"Peltason","year":"2010","journal-title":"J. Chem. Inf. Model."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826009466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826009466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:03:45Z","timestamp":1791407025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826009466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":120,"alternative-id":["S0045206826009466"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110410","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Green synthesis of N-aryl-1-(2-bromo-4-methyl phenyl)-1H-tetrazol-5-amines as novel anti-cancer agents targeting tubulin-Combretastatin A4 complex and human non-small cell lung cancer cell lines","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110410","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110410"}}